grant

Long-Term Effects of Intracerebral Hemorrhage on Behavior and Inflammation

Organization YALE UNIVERSITYLocation NEW HAVEN, UNITED STATESPosted 1 Sept 2025Deadline 31 Aug 2027
NIHUS FederalResearch GrantFY20255-HT5-Hydroxytryptamine5HTAcquired brain injuryAffective DisordersAgingAnimal ModelAnimal Models and Related StudiesAnxietyApoplexyAssayAutomobile DrivingBehaviorBehavioralBindingBioassayBiological AssayBleedingBlood VesselsBody TissuesBrainBrain DiseasesBrain DisordersBrain EdemaBrain InjuriesBrain Nervous SystemBrain SwellingBrain Vascular AccidentCNS Nervous SystemCause of DeathCell BodyCell Communication and SignalingCell SignalingCellsCentral Nervous SystemCerebral Brain HemorrhageCerebral HemorrhageCerebral Parenchymal HemorrhageCerebral StrokeCerebral hemisphere hemorrhageCerebrovascular ApoplexyCerebrovascular StrokeCerebrum HemorrhageCessation of lifeChemotactic CytokinesChronicCognitionCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive function abnormalCollagen PeptidaseCollagen-Degrading EnzymeCyclic GMPDNADNA DamageDNA InjuryDataDeathDeoxyribonucleic AcidDifferences between sexesDiffers between sexesDisturbance in cognitionDouble-Stranded DNADown-RegulationELISAEmotional DepressionEncephalonEncephalon DiseasesEnteramineEnzyme-Linked Immunosorbent AssayFe elementFemaleFundingGene ActivationGene TranscriptionGenesGenetic TranscriptionGoalsGrantGuanosine Cyclic MonophosphateHematomaHemorrhageHippophaineHomologous Chemotactic CytokinesHortega cellHumanIFNIFN activationImmuneImmune Cell ActivationImmune responseImmunesImmunoblottingImmunohistochemistryImmunohistochemistry Cell/TissueImmunohistochemistry Staining MethodImpaired cognitionInfiltrationInflammationInflammatoryInjectionsInjuryInnate Immune ResponseIntercrinesInterferon ActivationInterferon ReceptorInterferon Type IInterferonsIntracellular Communication and SignalingIntracerebral HemorrhageIntracranial CNS DisordersIntracranial Central Nervous System DisordersIntracranial EdemaIronLinkLong-Term EffectsMapsMeasuresMental DepressionMiceMice MammalsMicrogliaModelingModern ManMolecular InteractionMood DisordersMoodsMurineMusNational Institutes of HealthNerve CellsNerve Transmitter SubstancesNerve UnitNeural CellNeuraxisNeurocyteNeuroimmuneNeuronsNeurotransmittersOperative HemorrhageOutcomePathogenesisPathway interactionsPatientsPeripheralPhagocytosisPhasePhenotypePhosphorylationPredispositionProtein PhosphorylationQOLQuality of lifeRNA ExpressionReceptor SignalingRecoveryReportingRoleRuptureSIS cytokinesSTAT1STAT1 geneSTAT91SerotoninSex DifferencesSexual differencesShapesSignal TransductionSignal Transduction SystemsSignalingSingle cell seqStimulator of Interferon GenesStrokeSurgical Blood LossSurgical HemorrhageSurvivorsSusceptibilityTestingTissuesTranscriptionUnited States National Institutes of HealthWestern BlottingWestern ImmunoblottingWhole BloodWorkanxiousbehavior outcomebehavior phenotypebehavioral outcomebehavioral phenotypingbiological signal transductionblood lossbrain attackbrain cellbrain damagebrain-injuredcGAMP STINGcGAMP-STINGcGAMP/STINGcGAS/STINGcGMPcatalystcerebral vascular accidentcerebrovascular accidentchemoattractant cytokinechemokinecognitive assessmentcognitive dysfunctioncognitive losscognitive testingcollagenasecyclic GMP-AMP synthase/STINGcytokinedepressiondepression symptomdepressivedepressive symptomsdisabilitydrivingds-DNAdsDNAenzyme linked immunoassayexperienceexperimentexperimental researchexperimental studyexperimentsfemale patientsfirst respondergitter cellglial activationglial cell activationhigh riskhost responsehuman dataimmune activationimmune system responseimmunoresponseimprovedin vivoinflammation markerinflammatory markerinjuriesinjury recoveryinjury to tissueinnate immune mechanismsmalemesogliamicroglial cellmicrogliocytemodel of animalmouse modelmurine modelneural inflammationneuroinflammationneuroinflammatoryneuronalnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapypathwaypatients being femalepatients being womenpatients who are femaleperivascular glial cellpost stroke depressionpoststroke depressionprogramsprotein blottingrecovery after injuryrecovery following injuryrecovery post injuryresponsesexsex based differencessex-dependent differencessex-related differencessex-specific differencessingle cell next generation sequencingsingle cell sequencingsocial rolestroke survivorstrokedstrokestissue injurytranscriptomicsvascularwet brainwomen patients
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Stroke is the second highest cause of death and the leading cause of disability worldwide. Intracerebral

hemorrhage (ICH) is the second most prevalent form of stroke and has the highest disability rate among

survivors1. ICH survivors remain at high risk for negative outcomes including rebleeding, depression, anxiety,

and progressive cognitive impairment, which may be due to chronic neuroinflammation2. The early immune cell

response to ICH is well studied—pro-inflammatory cytokines, activation of microglia, and infiltration of

peripheral immune cells increase, followed by reparative stages of reduced brain edema and phagocytosis3.

However, the long-term effects of innate immune cell activation is largely unknown. Our preliminary work

suggests that microglia, the resident immune cells of the brain, show continued activation 28- and 60-days

following ICH, suggesting long-term inflammation that persisted more in females. Indeed, we also detect

behavioral deficits in females but not males at late timepoints, suggesting there may be a link between chronic

inflammation and behavioral phenotype. I hypothesize that continued activation of innate immune cells in

the brain contribute to chronic neuroinflammation and behavioral changes at late timepoints in a sex-

specific manner. The goal of this project is to utilize an in-vivo mouse model of ICH, collagenase injection, to

map microglial activation and behavioral changes following stroke. Aim 1 will elucidate the mechanism driving

inflammatory phenotypes in microglia and the catalyst of interferon activation. Aim 2 will establish the factors

leading to downstream interferon stimulated genes, characterize changes in the neurotransmitter serotonin

following brain injury, and map out differences in mice behavior depending on sex. Aim 3 will explore human

data to determine whether inflammatory markers are still upregulated years later in stroke survivors, and if they

correlate with depression and anxiety. These experiments will map out the long-term effects of innate immune

activation on behavior in both animal models and patients. My results have the potential to shape our

understanding of long-term effects of neuroinflammation in order to improve survivors’ quality of life following

stroke, while also having implications for brain injury, degeneration, and aging.

Grant Number: 1F31NS141558-01A1
NIH Institute/Center: NIH

Principal Investigator: Efrat Abramson

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →